PMID: 9648004Jul 2, 1998Paper

Perinatal hemolytic disease. Part 2: Prevention and management

Journal de gynécologie, obstétrique et biologie de la reproduction
P HohlfeldJ D Tissot

Abstract

There has been a dramatic reduction in the incidence of neonatal mortality due to fetal hemolytic disease since the introduction of Rhesus prophylaxis. Although routinely used since 1968, the exact mode of action of anti-D IgGs is still not fully understood. Notable advances have taken place in the screening and the management of fetal hemolytic disease. This article describes the antibody detection in the mother, and the fetal management with ultrasound amniocentesis, fetal blood sampling and intrauterine transfusions. Finally, the postnatal management is also considered.

Related Concepts

Related Feeds

Blood Group Incompatibility

Blood group incompatibility between donor and recipient has been associated with poor transplant outcomes. Discover the latest research on blood group icompatibility here.

Related Papers

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
B Langer
The Ulster Medical Journal
D C WilsonM M Reid
Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
Mirta StarcevićMonika Kukuruzović
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
A Greenough
© 2022 Meta ULC. All rights reserved